NEWS News Release

U-Factor Co., Ltd., a Drug Discovery Venture Focused on Developing Therapeutics Using Stem Cell Culture Supernatant, Launches Second Phase of Ophthalmic Disease Research in Collaboration with Keio University School of Medicine

U-Factor Co., Ltd. Signs Joint Research Agreement with Tokyo Women’s Medical University for the Development of Therapeutics Using U-Factor solution

Announcement of the Commencement of a Specific Clinical Study for ALS

U-Factor Co., Ltd. Signs Agreement with AIST Solutions

Filed a patent for a dry eye treatment in collaboration with Keio University

We have invented a new culture supernatant in collaboration with AIST

Commencement of joint research with Keio University School of Medicine

Commencement of Joint Research with the National Institute of Advanced Industrial Science and Technology (AIST)

We were featured in the Nikkei

We have launched the website